483 Elizabeth Plimack, MD, MS Sep 2019

483 Elizabeth Plimack, MD, MS Sep 2019

Christopher Bastedo FDA, Stephanie Mangigian FDA, Anastasia Offordile FDA, Anastasia Onuorah FDA$119.00 - Available Now

FDA investigators audited the Elizabeth Plimack, MD, MS - Philadelphia, PA, United States facility and issued inspectional observations (via FDA 483) on 26 Sep 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 26 Sep 2019
  • Location: Philadelphia, United States
  • FEI: 3015360837
Add To Cart